| Year |
Citation |
Score |
| 2022 |
Rao AM, Popper SJ, Gupta S, Davong V, Vaidya K, Chanthongthip A, Dittrich S, Robinson MT, Vongsouvath M, Mayxay M, Nawtaisong P, Karmacharya B, Thair SA, Bogoch I, Sweeney TE, et al. A robust host-response-based signature distinguishes bacterial and viral infections across diverse global populations. Cell Reports. Medicine. 3: 100842. PMID 36543117 DOI: 10.1016/j.xcrm.2022.100842 |
0.519 |
|
| 2022 |
Anahtar M, Chan LW, Ko H, Rao A, Soleimany AP, Khatri P, Bhatia SN. Host protease activity classifies pneumonia etiology. Proceedings of the National Academy of Sciences of the United States of America. 119: e2121778119. PMID 35696579 DOI: 10.1073/pnas.2121778119 |
0.52 |
|
| 2022 |
Liu YE, Saul S, Rao AM, Robinson ML, Agudelo Rojas OL, Sanz AM, Verghese M, Solis D, Sibai M, Huang CH, Sahoo MK, Gelvez RM, Bueno N, Estupiñan Cardenas MI, Villar Centeno LA, et al. An 8-gene machine learning model improves clinical prediction of severe dengue progression. Genome Medicine. 14: 33. PMID 35346346 DOI: 10.1186/s13073-022-01034-w |
0.441 |
|
| 2022 |
Buturovic L, Zheng H, Tang B, Lai K, Kuan WS, Gillett M, Santram R, Shojaei M, Almansa R, Nieto JÁ, Muñoz S, Herrero C, Antonakos N, Koufargyris P, Kontogiorgi M, ... ... Rao AM, et al. A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections. Scientific Reports. 12: 889. PMID 35042868 DOI: 10.1038/s41598-021-04509-9 |
0.517 |
|
| 2021 |
Zheng H, Rao AM, Dermadi D, Toh J, Murphy Jones L, Donato M, Liu Y, Su Y, Dai CL, Kornilov SA, Karagiannis M, Marantos T, Hasin-Brumshtein Y, He YD, Giamarellos-Bourboulis EJ, et al. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity. PMID 33765435 DOI: 10.1016/j.immuni.2021.03.002 |
0.529 |
|
| 2018 |
Rao AM. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response Jama Network Open. 6. PMID 30646264 DOI: 10.1001/jamanetworkopen.2018.3779 |
0.34 |
|
| 2018 |
Warsinske HC, Rao AM, Moreira FMF, Santos PCP, Liu AB, Scott M, Malherbe ST, Ronacher K, Walzl G, Winter J, Sweeney TE, Croda J, Andrews JR, Khatri P. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response. Jama Network Open. 1: e183779. PMID 30646264 DOI: 10.1001/jamanetworkopen.2018.3779 |
0.476 |
|
| 2018 |
Cheung P, Vallania F, Dvorak M, Chang SE, Schaffert S, Donato M, Rao A, Mao R, Utz PJ, Khatri P, Kuo AJ. Single-cell epigenetics - Chromatin modification atlas unveiled by mass cytometry. Clinical Immunology (Orlando, Fla.). PMID 29960011 DOI: 10.1016/J.Clim.2018.06.009 |
0.428 |
|
| 2018 |
Warsinske H, Rao A, Moreira FMF, Santos PCPD, Liu A, Scott M, Malherbe S, Ronacher K, Walzl G, Winter J, Sweeney TE, Croda J, Andrews JR, Khatri P. 119. Prospective Validation of a 3-Gene Signature for Tuberculosis Diagnosis, Predicting Progression and Evaluating Treatment Response Open Forum Infectious Diseases. 5: S5-S5. DOI: 10.1093/Ofid/Ofy209.010 |
0.494 |
|
| Show low-probability matches. |